학술논문

Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study
Document Type
Article
Source
In Annals of Oncology September 2022 33(9):929-938
Subject
Language
ISSN
0923-7534